APA

Dickson M. A., Schwartz G. K., Keohan M. L., D'Angelo S. P., Gounder M. M., Chi P., Antonescu C. R., Landa J., Qin L., Crago A. M., Singer S., Koff A. & Tap W. D. (20170713). Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. : JAMA oncology.

Chicago

Dickson Mark A, Schwartz Gary K, Keohan Mary Louise, D'Angelo Sandra P, Gounder Mrinal M, Chi Ping, Antonescu Cristina R, Landa Jonathan, Qin Li-Xuan, Crago Aimee M, Singer Samuel, Koff Andrew and Tap William D. 20170713. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. : JAMA oncology.

Harvard

Dickson M. A., Schwartz G. K., Keohan M. L., D'Angelo S. P., Gounder M. M., Chi P., Antonescu C. R., Landa J., Qin L., Crago A. M., Singer S., Koff A. and Tap W. D. (20170713). Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. : JAMA oncology.

MLA

Dickson Mark A, Schwartz Gary K, Keohan Mary Louise, D'Angelo Sandra P, Gounder Mrinal M, Chi Ping, Antonescu Cristina R, Landa Jonathan, Qin Li-Xuan, Crago Aimee M, Singer Samuel, Koff Andrew and Tap William D. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. : JAMA oncology. 20170713.